GlassScriptPhysician profile
Ritu Madan
NPI 1396746517
$1,682.51
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $407 · 2020: $392 · 2021: $475 · 2022: $409.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $345.81 | 2019-2022 | |
| Lilly USA, LLC | $229.74 | 2019-2021 | |
| Abbvie INC. | $191.38 | 2019-2022 | |
| Daiichi Sankyo INC. | $148.14 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $134.89 | 2022 | |
| Novo Nordisk INC | $117.16 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $69.82 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $48.89 | 2020-2022 | |
| Pfizer INC. | $46.09 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.52 | 2020-2021 | |
| Dermira, INC. | $30.27 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $27.73 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $25.31 | 2021 | |
| Celgene Corporation | $25.12 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $19.18 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $18.82 | 2020 | |
| Amarin Pharma, INC. | $18.05 | 2019 | |
| Radius Health, INC. | $17.87 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $17.08 | 2019 | |
| Avanir Pharmaceuticals, INC. | $15.20 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $15.01 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.42 | 2020 | |
| Eisai INC. | $14.38 | 2020 | |
| Ucb, INC. | $12.43 | 2019 | |
| Jazz Pharmaceuticals INC. | $11.75 | 2021 | |
| Glaxosmithkline, LLC. | $11.46 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $10.99 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ritu Madan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.